Insight Molecular Diagnostics

IMDX

Börsenwert 98,8 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Broadwood Capital New York	18,6 Mio. $	–	–	–
2	2 Bridgeway Capital Management Houston, Texas	705.000 $	–	–	–
3	3 Vanguard Group Malvern, Pennsylvania	683.000 $	+27.529 $	+250	+5 %
4	MHP 4 Manatuck Hill Partners Westport, Connecticut	592.000 $	+149.540 $	+1.358	+48 %
5	5 BlackRock Institutional Trust San Francisco, California	488.000 $	–	–	–
6	AG 6 Artal Group Luxembourg	452.000 $	–	–	–
7	7 Destination Wealth Management Walnut Creek, California	209.000 $	–	–	–
8	8 Geode Capital Management Boston, Massachusetts	105.000 $	–	–	–
9	9 Family Management New York	84.000 $	+65.850 $	+598	Neu
10	10 BlackRock Fund Advisors San Francisco, California	78.000 $	+24.556 $	+223	+67 %
11	11 PNC Financial Services Group Pittsburgh, Pennsylvania	28.000 $	–	–	–
12	12 Morgan Stanley New York	8.000 $	+6.056 $	+55	+2.750 %
13	13 Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada	7.000 $	-4.405 $	-40	-42 %
14	14 BlackRock Investment Management Wilmington, Delaware	5.000 $	–	–	–
15	15 Carroll Financial Associates Charlotte, North Carolina	5.000 $	–	–	–
16	16 UBS Group Zurich, Switzerland	5.000 $	+3.414 $	+31	+775 %
17	17 Elgethun Capital Management Sioux Falls, South Dakota	5.000 $	+3.854 $	+35	Neu
18	18 Mivtachim The Workers Social Insurance Fund Tel Aviv, Israel	4.000 $	–	–	–
19	19 BlackRock Advisors Wilmington, Delaware	3.000 $	–	–	–
20	20 Bank of America Charlotte, North Carolina	3.000 $	+991 $	+9	+64 %
21	21 MUFG Americas New York	3.000 $	+2.092 $	+19	Neu
22	22 Royal Bank of Canada Toronto, Ontario, Canada	2.000 $	-551 $	-5	-29 %
23	23 Creative Planning Overland Park, Kansas	2.000 $	–	–	–
24	24 Fifth Third Bancorp Cincinnati, Ohio	1.000 $	–	–	–
25	25 Harel Insurance Investments & Financial Services Ramat Gan, Israel	1.000 $	–	–	–

Insight Molecular Diagnostics IMDX Börsenwert 98,8 Mio. $

Insight Molecular Diagnostics

IMDX

Börsenwert 98,8 Mio. $